Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418–1425. doi: 10.1056/NEJMoa1404505. pmid:24738640
[4]
Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol, ST, et al. Estimating the Future Number of Cases in the Ebola Epidemic—Liberia and Sierra Leone, 2014–2015. MMWR September 26, 2014; Supplement 1–14.
[5]
WHO Ebola Response Team. Ebola Virus Disease in West Africa—The First 9 Months of the Epidemic and Forward Projections. N Engl J Med 2014; 371:1481–1495. doi: 10.1056/NEJMoa1411100. pmid:25244186
[6]
Centers for Disease Control and Prevention. CDC Ebola Outbreak in West Africa—Case Counts.
[7]
Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical Care of Two Patients with Ebola Virus Disease in the United States. N Engl J Med 2014; 371(25):2402–2409. doi: 10.1056/NEJMoa1409838. pmid:25390460
[8]
Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, et al. Successful Delivery of RRT in Ebola Virus Disease. J Am Soc Nephrol 2014 26:31–37. doi: 10.1681/ASN.2014111057. pmid:25398785
[9]
Hill CE, Burd EM, Kraft CS, Ryan EL, Duncan A, Winkler AM, et al. Laboratory test support for ebola patients within a high-containment facility. Lab Med 2014; 45(3):e109–11. doi: 10.1309/LMTMW3VVN20HIFS. pmid:25184220
[10]
Smith EL, Rice KL, Feistritzer NR, Hill C, Vanairsdale S, Gentry J. Care of patients with ebola virus disease. J Contin Educ Nurs 2014 Nov; 45(11):479–81. doi: 10.3928/00220124-20141027-12. pmid:25365183
[11]
Fox J, Bornstein B, Grant S (2015) Emory Healthcare Ebola Preparedness Protocols.
[12]
Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278(5), 399–411. pmid:9244332 doi: 10.1001/jama.278.5.399
[13]
Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome. J. Virol 2004; 78: 4330–4341. pmid:15047846 doi: 10.1128/jvi.78.8.4330-4341.2004
[14]
Evans DP, del Rio C (2015) Ebola Virus Disease: An Evolving Epidemic.
[15]
Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ et al. The Use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin Infect Dis. 2015 Apr 22. pii: civ334. Epub ahead of print.
[16]
Moreno CC, Kraft CS, Vanairsdale S, Kandiah P, Klopman MA et al. Performance of Bedside Diagnostic Ultrasound in an Ebola Isolation Unit: The Emory University Hospital Experience. Am J Roentgenol 2015; 204: 1157–1159. doi: 10.2214/ajr.15.14344
[17]
McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, et al. Human Ebola Virus Infection Results in Substantial Immune Activation. Proc Natl Acad Sci USA 2015; 112: 4719–4724. doi: 10.1073/pnas.1502619112. pmid:25775592
[18]
Lai L, Davey R, Beck A, Xu Y, Suffredini AF et al. Emergency Postexposure Vaccination with Vesicular Stomatitis Virus-vectored Ebola Vaccine after Needlestick. JAMA 2015; 313: 1249–55. doi: 10.1001/jama.2015.1995. pmid:25742465
[19]
Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM al. Persistence of Ebola Virus in Ocular Fluid during Convalescence N Engl J Med 2015; 372: 2423–2427. doi: 10.1056/nejmoa1500306
[20]
Emory University (2015) Ebola Faculty and Community Discussion Forum.
